Section Arrow
Quote
BGLC.NASDAQ
- BioNexus Gene Lab Corp
(Financial Status)
Quotes are at least 15-min delayed:2024/06/05 10:49 EDT
Last
 0.476751
-0.019549 (-3.94%)
Day High 
0.485 
Prev. Close
0.4963 
1-M High
0.678 
Volume 
175.11K 
Bid
0.4765
Ask
0.48
Day Low
0.4616 
Open
0.4616 
1-M Low
0.4202 
Market Cap 
86.22M 
Currency USD 
P/E -- 
%Yield 0 
10-SMA 0.5 
20-SMA 0.54 
50-SMA 0.6 
52-W High 17.88 
52-W Low 0.31 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.19/--
Enterprise Value
86.32M
Balance Sheet
Book Value Per Share
0.53
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
9.77M
Operating Revenue Per Share
0.06
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
CRKNCrown Electrokinetics Corp0.088-0.0165-15.79%-- 
ALTMArcadium Lithium plc4.265+0.075+1.79%5.6PE
LINLinde plc432.5425+1.4025+0.33%33.47PE
AVTRAvantor24.4625+0.2825+1.17%63.63PE
ALBAlbemarle Corp119.04+0.73+0.62%42.87PE
Quotes are at least 15-min delayed：2024/06/05 10:49 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the earlydetection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.